Fact-check: Recent X posts from March 3, 2026, actively discuss STAAR Surgical's Q4 2025 earnings call results, including $57.8M revenue and EPS miss, confirming the event in real-time. Seeking Alpha published the official transcript shortly after the March 3 call, matching company announcements and investor site records. The claim is fully verified and supported by current reporting.
STAAR Surgical Company (STAA) Q4 2025 Earnings Call Transcript
STAAR Surgical Company (NASDAQ: STAA) held its Q4 2025 earnings call, reporting financial results for the fourth quarter and full year 2025. The medical device company, known for its implantable collamer lenses, discussed revenue performance, operational updates, and forward guidance with analysts and investors.